Welcome everyone to Episode 100 of The Stem Cell Podcast. As always go to stemcellpodcast.com for all of our episodes and to sign up for our newsletter.
The Science Round Up
For this week’s round-up, STEMCELL Technologies would like to know what you think about the podcast. Please go to our website (stemcellpodcast.com) and click on the picture of the Starbucks mug to take our 2-minute survey to let us know how we’re doing and what we can do to improve the show. You can also enter to win a $10 Starbucks card!
This week, in the world-famous Science Round Up, we discuss the latest science/stem cell news including:
- Hurricanes and climate change.
- Genes to predict flu vaccine efficacy.
- Using Zika virus to treat brain cancer
- Parkinson’s monkeys and stem cell transplants.
The interview with Kevin McCormack
In the interview portion of this episode, STEMCELL Technologies introduces the product: mTeSR™1, one of the most highly validated, feeder-free maintenance medium for human embryonic stem cells and human induced pluripotent stem cells. Here are the highlights of mTeSR™1:
- This medium has been used in over 1,500 peer-reviewed publications.
- mTeSR™1 is cGMP grade, manufactured under a cGMP quality management system. It ensures the highest quality and consistency for reproducible results.
- This flexible maintenance medium supports multiple feeding and passaging timelines to suit your own schedule, and can be combined with your cell culture matrix and passaging reagent of choice.
- mTeSR™1 is the medium of choice for feeder-free human pluripotent stem cell genome editing using CRISPR/Cas9.
- Learn more at stemcell.com/mtesr1
For the interview portion of the show of our 100th episode, The Stem Cell Podcast and STEMCELL Technologies welcome Kevin McCormack from the California Institute of Regenerative Medicine, or CIRM, to talk about all of CIRM’s progress, past, present, and future…CIRM was created in 2004 to translate stem cell discoveries into therapies, and we will talk to Kevin about the progress this funding has made.
After the interview, we close the show with a signature SCP rant.[Read more…]